Sreeram Ramagopalan

Ram Ramagopalan is the CEO at the consultancy firm Kairos Advisory. He previously led Real World Evidence teams at Roche and Bristol Myers Squibb. Ram’s career to date has focussed on leveraging real-world evidence to demonstrate product value and for Health Technology (HTA) and payer assessments to obtain and maintain reimbursement of medicines. Ram has significant experience in strategically planning and utilising routinely collected data for health economics and outcomes research and market access purposes. Ram holds a PhD in Epidemiology from the University of Oxford, an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine and an MSc in Health Economics from the London School of Economics and Political Science. He is an international expert in real world evidence with over 300 journal publications. He is an academic editor for the journal PLoS One, on the editorial board for the journal BMC Medicine, and a Visiting Senior Lecturer at the Centre for Pharmaceut